The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126973583 12697358 3 F 2016 20160921 20160830 20160928 EXP US-JNJFOC-20160808693 JOHNSON AND JOHNSON 33.64 YR A F Y 0.00000 20160928 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126973583 12697358 1 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) Y U 0 5 MG/KG LYOPHILIZED POWDER
126973583 12697358 2 PS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) 6TH INFUSION Y U 103772 5 MG/KG LYOPHILIZED POWDER
126973583 12697358 3 SS TYLENOL ACETAMINOPHEN 1 Oral U U 19872 UNSPECIFIED
126973583 12697358 4 SS TYLENOL ACETAMINOPHEN 1 Oral U U 19872 650 MG UNSPECIFIED
126973583 12697358 5 SS BENADRYL DIPHENHYDRAMINE HYDROCHLORIDE 1 Oral U U 999999 25 MG UNSPECIFIED
126973583 12697358 6 SS TRAMADOL. TRAMADOL 1 Unknown U U 20281 UNSPECIFIED
126973583 12697358 7 C LIALDA MESALAMINE 1 Unknown D 0 4.8 G UNSPECIFIED
126973583 12697358 8 C IMURAN AZATHIOPRINE 1 Unknown D 0 UNSPECIFIED
126973583 12697358 9 C BENTYL DICYCLOMINE HYDROCHLORIDE 1 Unknown D 0 UNSPECIFIED
126973583 12697358 10 C MAXALT RIZATRIPTAN BENZOATE 1 Unknown D 0 10 MG UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126973583 12697358 1 Colitis ulcerative
126973583 12697358 2 Colitis ulcerative
126973583 12697358 4 Premedication
126973583 12697358 5 Premedication
126973583 12697358 6 Product used for unknown indication
126973583 12697358 7 Crohn's disease
126973583 12697358 10 Headache

Outcome of event

Event ID CASEID OUTC COD
126973583 12697358 OT
126973583 12697358 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126973583 12697358 Chest pain
126973583 12697358 Drug hypersensitivity
126973583 12697358 Exposure during pregnancy
126973583 12697358 Flushing
126973583 12697358 Hypoaesthesia
126973583 12697358 Infusion related reaction
126973583 12697358 Laryngeal oedema
126973583 12697358 Lip swelling
126973583 12697358 Rash

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126973583 12697358 1 20160301 20160805 0
126973583 12697358 2 20160805 0
126973583 12697358 4 20160805 0
126973583 12697358 5 20160805 0
126973583 12697358 7 2015 0
126973583 12697358 10 20120307 0